Treatment of Mental Problems in General Practice

1987 ◽  
Vol 15 (3) ◽  
pp. 131-137 ◽  
Author(s):  
Gunnar Tellnes ◽  
Arild Bjørndal ◽  
Per Fugelli
Keyword(s):  
General Practice ◽  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Drug Users ◽  
Local Community ◽  
Treatment And Prevention ◽  
Defined Daily Doses ◽  
Mental Problems ◽  
One Year ◽  
Chronic Use

The aim of the study was to provide a basis for improving the treatment and prevention of mental problems in a defined local community. The prescribing of psychotropic drugs has been recorded as well as the use of non-drug therapy and the factors which worsened the patients' mental problems. The rate of psychotropic drug-users was 15% for females and 9% for males. The total prescribing during one year amounted to 59 defined daily doses (DDD) per thousand inhabitants per day. Hypnotics/sedatives constituted 30%, anti-histamines 23%, neuroleptics 18%, minor tranquillizers 16%, and antidepressants 13%. About 1/4 of the psychotropic drug-users was prescribed more than 180 DDD per year, representing a risk group for chronic use. The majority of all psychotropic drugs (65%) was prescribed through indirect contacts implying a danger of developing “repeat prescription syndromes”. Less than one half of the patients who might have benefited from referral to a psychiatrist had, in fact, been referred during the previous three years. Somatic disease (among the psychotropic drug-users) and illness among other family members were frequently reported as worsening factors. This indicates the importance of holistic therapy and prophylaxis in general practice. Among our advice for prevention of mental problems to the local authorities was the arrangement of weekly social meetings and clubs for disabled pensioners and elderly people.

scholarly journals Perfil de usuários de psicofármacos atendidos em uma farmácia comunitária do alto sertão paraibano

2016 ◽  
Vol 6 (1) ◽  
pp. 01
Author(s):  
Nathalia Minelli Medeiros de Sousa ◽  
Natália Bitú Pinto ◽  
Francileuda Batista de Almeida ◽  
Neurislene Da Silva Maciel ◽  
Symara Abrantes Albuquerque de Oliveira Cabral ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Community Pharmacy ◽  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Drug Users ◽  
Public Health Problem ◽  
Structured Interview ◽  
Adherence To Treatment ◽  
One Year ◽  
The City

<p>O estudo teve o objetivo de identificar o perfil dos usuários de psicofármacos atendidos em uma farmácia comunitária no município de Cajazeiras - PB. A pesquisa é do tipo exploratória descritiva, com abordagem quantitativa. A coleta de dados foi realizada em agosto a outubro de 2011, com uma entrevista estruturada aplicada a uma amostra de140 clientes. Os resultados mostram que 79% da população estudada foram mulheres, apresentando idade entre 40 e 49 anos. O Clonazepam foi o medicamento mais consumido; 40% utilizavam a mais de um ano; 94% relataram ter tido melhoras no seu quadro clínico após o uso; 42% afirmaram usar esse medicamento para tratamento de insônia; 52% responderam que fazem uso de outros medicamentos concomitantemente ao tratamento com psicofármacos, o que é um dado importante devido às interações medicamentosas. Assim, esta havendo um aumento da incidência de transtornos psiquiátricos, o que é um problema de saúde pública, gerando um impacto social e econômico. Dessa forma, é importante que o farmacêutico oriente os pacientes com relação ao uso de psicofármacos, a fim de evitar efeitos tóxicos e interações medicamentosas, e buscando aumentar a eficácia do tratamento e reduzindo a falta de adesão ao tratamento.</p><p align="center"><strong><em>Profile of psychotropic drug users treated in a Community Pharmacy of Upper Paraíba backwoods</em></strong><em></em></p><pre><strong>ABSTRACT:</strong>. The study aimed to identify the profile of psychotropic drug users seen at a community pharmacy in the city of Cajazeiras - PB. The research is descriptive exploratory with a quantitative approach. Data collection was conducted in August-October 2011, with a structured interview applied to a sample of 140 customers. The results show that 79% of the population were women, with ages ranging from 40 to 49 years. The Clonazepam was the most consumed drug; 40% used for more than one year; 94% reported having had improvements in their clinical condition after use; 42% said they use this medication to treat insomnia; 52% answered that they use other drugs concomitantly to treatment with psychotropic drugs, which is an important data due to drug interactions. Thus, this having an increased incidence of psychiatric disorders, which is a public health problem, generating a social and economic impact. Thus, it is important that the east pharmacist patients regarding the use of psychotropic drugs in order to avoid toxic effects and drug interactions, and seeking to increase the effectiveness of treatment and reduce the lack of adherence to treatment.</pre>

scholarly journals Psychotropic drug purchases among Finnish disability pension applicants with mental disorders

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
R Perhoniemi ◽  
J Blomgren ◽  
M Laaksonen ◽  
A Tuulio-Henriksson
Keyword(s):  
Mental Disorders ◽  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Disability Pension ◽  
Bipolar Disorders ◽  
Diagnostic Group ◽  
Behavioral Disorder ◽  
Occupational Class ◽  
Accurate Identification ◽  
Defined Daily Doses

Abstract Purpose Trajectories of psychotropic drug purchases around disability pension process have only been studies among awarded applicants. The aim was to follow and compare psychotropic drug purchases between awarded and rejected applicants before and after the application ruling, and to analyse whether such differences are affected by diagnostic group and sociodemographic background. Methods A representative 70% sample of Finnish adults applying disability pension due to mental or behavioral disorder in 2009-2011 (N = 18,087) were followed for four eight years in three-month periods. Registers of purchased psychotropic drugs measured in defined daily doses (DDDs), gender, age, occupational class, unemployment history, and diagnostic group were used. The DDD levels and trends were analysed using growth curve models. Results The average purchased DDDs of psychotropic drugs increased before the application ruling and decreased gradually thereafter among both awarded and rejected applicants. Before the application ruling the DDD level was higher for the rejected applicants. However, the increase in DDDs was steeper for awarded applicants. The inversed U-curve of purchase amount was most prominent awarded applicants in diagnostic groups of bipolar disorders, depression, anxiety disorders and schizophrenia. The results partly varied between sociodemographic groups. Conclusions The early high level of psychotropic drug purchases of rejected disability pension applicants signals long running ill-health, calling for earlier measures to uphold their functional ability. Respectively, for awarded applicants, the steep DDD increase before the ruling may reflect accurate identification of worsening condition but also access to precise treatment. Key messages Rejected disability pension applicants with mental disorders suffer from long-running mental ill-health, calling for earlier measures to uphold their mental health and prevent the pension process. Awarded disability pension applicants with mental disorders may have access to more precise treatment, but their worsening condition appear to be accurately identified by Finnish system.

Prevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals

2020 ◽  
Vol 53 (03) ◽  
pp. 133-137
Author(s):  
Julia C. Stingl ◽  
Katja S. Just ◽  
Marlen Schurig ◽  
Miriam Böhme ◽  
Michael Steffens ◽  
...  
Keyword(s):  
Older Adults ◽  
Drug Use ◽  
Psychotropic Drug ◽  
Adverse Drug Reactions ◽  
Psychotropic Drugs ◽  
Drug Users ◽  
Prospective Observational Study ◽  
Drug Reactions ◽  
Specific Patient ◽  
Psychotropic Drug Use

Abstract Introduction The prevalence of psychotropic drug use in our society is increasing especially in older adults, thereby provoking severe adverse drug reactions (ADR). To identify specific patient risk profiles associated with psychotropic drug use in the situation of polymedication. Methods Cases of ADRs in general emergency departments (ED) collected within the multi-center prospective observational study (ADRED) were analyzed (n=2215). We compared cases with use of psychotropic drugs and without concerning their clinical presentation at the ED. Results A third of patients (n=731, 33%) presenting to the ED with an ADR took at least 1 psychotropic drug. Patients with psychotropic drug use tended to be older, more often female, and took a higher number of drugs (all p<0.001). The frequency of falls was almost 3 times higher than compared to the non-psychotropic drug group (10.5 vs. 3.9%, p<0.001), and similar syncope was also more often seen in the psychotropic drug users (8.8 vs. 5.5%, p=0.004). The use of psychotropic drugs increased the risk for falls by a factor of 2.82 (OR, 95% CI (1.90–4.18)), when adjusting for gender, age, numbers of pre-existing diseases, and drugs, respectively. Discussion The association of psychotropic drug use with fall and syncope in combination with polymedication and older age leads to the suspicion that psychotropic drugs might be potentially harmful in specific risk populations such as older adults. It may lead us to thoroughly weigh the benefit against risk in a patient-oriented way, leading to an integrative personalized therapy approach.

Psychotropic-Drug Prescribing for Women

1991 ◽  
Vol 158 (S10) ◽  
pp. 30-35 ◽  
Author(s):  
Heather Ashton
Keyword(s):  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Psychological Symptoms ◽  
Symptom Control ◽  
Child Rearing ◽  
Depression And Anxiety ◽  
Sociological Factors ◽  
The Social ◽  
Social Use ◽  
Chronic Use

The reasons for women in Europe and North America being prescribed over twice as many psychotropic drugs as men are complex. Psychiatric disorders such as depression and anxiety appear to be more common in women than in men, and women more commonly complain of psychological symptoms. There may be a gender bias in medical diagnosis and choice of medication. Sociological factors may also be involved, including the likelihood that women have fewer outlets than men for symptom control by activities outside the home (e.g. the social use of alcohol). Women also have special problems including pregnancy, lactation, child rearing and pre-menstrual tension. Probably, much use of psychotropic-drug use for women (and men) is inappropriate and not closely related to the symptoms or conditions for which they are prescribed. Furthermore, the chronic use of some psychotropic drugs, especially benzodiazepines, may compound the problem by inducing dependence and withdrawal symptoms.

scholarly journals Testing the Role of Emotion Dysregulation as a Predictor of Juvenile Recidivism

2021 ◽  
Vol 11 (1) ◽  
pp. 83-95
Author(s):  
Kalin Z. Salinas ◽  
Amanda Venta
Keyword(s):  
Emotion Regulation ◽  
Juvenile Offenders ◽  
Emotion Dysregulation ◽  
Longitudinal Research ◽  
Future Research ◽  
Individual Factor ◽  
Treatment And Prevention ◽  
One Year ◽  
The Individual

The current study proposed to determine whether adolescent emotion regulation is predictive of the amount and type of crime committed by adolescent juvenile offenders. Despite evidence in the literature linking emotion regulation to behaviour problems and aggression across the lifespan, there is no prior longitudinal research examining the predictive role of emotion regulation on adolescent recidivism, nor data regarding how emotion regulation relates to the occurrence of specific types of crimes. Our primary hypothesis was that poor emotion regulation would positively and significantly predict re-offending among adolescents. We tested our hypothesis within a binary logistic framework utilizing the Pathways to Desistance longitudinal data. Exploratory bivariate analyses were conducted regarding emotion regulation and type of crime in the service of future hypothesis generation. Though the findings did not indicate a statistically significant relation between emotion regulation and reoffending, exploratory findings suggest that some types of crime may be more linked to emotion regulation than others. In sum, the present study aimed to examine a hypothesized relation between emotion regulation and juvenile delinquency by identifying how the individual factor of dysregulated emotion regulation may have played a role. This study’s findings did not provide evidence that emotion regulation was a significant predictor of recidivism over time but did suggest that emotion regulation is related to participation in certain types of crime one year later. Directions for future research that build upon the current study were described. Indeed, identifying emotion regulation as a predictor of adolescent crime has the potential to enhance current crime prevention efforts and clinical treatments for juvenile offenders; this is based on the large amount of treatment literature, which documents that emotion regulation is malleable through treatment and prevention programming.

French patterns of psychotropic drug use

1990 ◽  
Vol 5 (5) ◽  
pp. 301-308
Author(s):  
V Kovess ◽  
M Ortun
Keyword(s):  
Drug Use ◽  
General Practitioners ◽  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Elderly Population ◽  
The Elderly ◽  
Population Surveys ◽  
Minor Tranquilizers ◽  
French People ◽  
Few Data

SummaryFrench publications on psychotropics are curiously few. Data are available and French consumption of psychotropics, at least minor tranquilizers has been consistently reported as being higher than that found in other countries. The authors attempt to answer three questions: is French consuption of psychotropics really higher than other countries? Who is consuming those drugs? In which context? After having reviewed comparative data on sales, data from population surveys are analysed together with samples of prescriptions by different categories of physicians. It seems likely that French people consume more anxiolytics but this does not apply to other psychotropic drugs. Given the fact that drugs are almost free of charge in France, it is always difficult to discriminate between what has been prescribed and what has been taken. Overconsumption of anxiolytics is due to the overconsumption of the elderly population (over 60). Minor tranquilizers are mainly prescribed by general practitioners for psychological reasons.

PRN Medication for Psychiatric Inpatients

1987 ◽  
Vol 32 (3) ◽  
pp. 199-203 ◽  
Author(s):  
John L. Craven ◽  
Peter M. Voore ◽  
George Voineskos
Keyword(s):  
Personality Disorder ◽  
Drug Use ◽  
Psychotropic Drug ◽  
Teaching Hospital ◽  
Psychotropic Medication ◽  
Psychotropic Drugs ◽  
Psychiatric Inpatient ◽  
Psychiatric Inpatients ◽  
Psychotropic Medications ◽  
Inpatient Units

Little is known about the extent of the use of prn psychotropic medication in psychiatric inpatient units. A survey of the prn prescription and administration of psychotropic drugs in a psychiatric teaching hospital revealed that a large number of inpatients were prescribed and administered such drugs on a prn basis. Although 50% of the prescriptions were never administered, only 25% were actively discontinued by physicians. A diagnosis of personality disorder was the factor most frequently associated with the rate of prn prescriptions and of administrations. A large number of prn prescriptions had no instructions for indications, minimum time spacing between doses or maximum daily dosage. It is suggested that hospitals monitor the prn use of psychotropic medications in their inpatient units, and explore the reasons for such use. Psychotropic drug use on a prn basis should preferably be reserved for emergencies, and the instructions of prn prescriptions should be clear and detailed.

Mental Disorders and the Use of Psychotropic Drugs in an 85-Year-Old Urban Population

1993 ◽  
Vol 5 (1) ◽  
pp. 33-48 ◽  
Author(s):  
Ingmar Skoog ◽  
Lars Nilsson ◽  
Sten Landahl ◽  
Bertil Steen
Keyword(s):  
Drug Therapy ◽  
Mental Disorders ◽  
Anxiety Disorders ◽  
Mental Disorder ◽  
Psychotropic Drug ◽  
Psychotropic Drugs ◽  
Urban Population ◽  
Depressive Disorders ◽  
Psychotic Disorders ◽  
Antidepressant Drug

The prevalence of mental disorders was studied in a representative sample of 85-year-old living in Gothenburg, Sweden, (n=494). All subjects were examined by a psychiatrist, whose diagnoses were defined according to the DSM-III-R criteria. In the sample, the prevalence of dementia was 29.8%, and of any other mental disorder was 24.3%. Psychotic disorders were present in 4.7%, depressive disorders in 12.6%, and anxiety disorders in 10.5%. Anxiety disorders were more common in women than in men. Of all subjects, 42.5% used a psychotropic drug (men 30.1%, women 47.6%, p<0.001), 34.2% used anxiolytic-sedatives, 14.0% used antidepressants, and 5.7% used neuroleptics. Women used significantly more anxiolytic-sedatives and antidepressants than did men. Of those with no mental disorders, 29.1% used a psychotropic drug. Although the prescription of psychotropic drugs was high, only one fifth of those with depressive disorders received antidepressant drug therapy and one tenth of those with psychotic disorders received neuroleptics.

scholarly journals COMPARISON OF THERAPEUTIC EFFICACY OF TOPICAL CORTICOSTEROID AND ORAL ZINC SULFATE-TOPICAL CORTICOSTEROID COMBINATION IN THE TREATMENT OF VITILIGO AT KMCH, KATIHAR, BIHAR

2020 ◽  
pp. 43-45
Author(s):  
Nadia Akram ◽  
Seeba Hussain ◽  
Debarshi Jana
Keyword(s):  
Topical Corticosteroid ◽  
Zinc Sulfate ◽  
Combination Group ◽  
Randomized Controlled ◽  
Treatment And Prevention ◽  
Supplemental Zinc ◽  
Significant Difference ◽  
One Year ◽  
Higher Doses

Background : Vitiligo is the most prevalent pigmentary disorder which occurs worldwide, with an incidence rate between 0.1-4 percent. It is anticipated that the discovery of biological pathways of vitiligo pathogenesis with provide novel therapeutic and prophylactic targets for future approaches to the treatment and prevention of vitiligo. The purposes of this study were evaluating the efficacy of supplemental zinc on the treatment of vitiligo. Methods : This randomized clinical trial was conducted for a period of one year. Thiry five patients among 86 participatnts were eligible to entrance to the study. The patients in two equal randomized groups took topical corticosteroid and comination of oral zinc sulfate-topical corticosteroid. Results : The of responses in the corticosteroid group and the zinc sulfat-corticosteroid combination group were 21.43% and 24.7% respectively. Conclusion : Although, the response to corticosteroid plus zinc sulfate was more than corticosteroid, there was no statistically significant difference between them. It appeared that more robust long-term randomized controlled trials on more patients, may be with higher doses of zinc sulfate, are needed to fully establish the efficacy of oral zinc in management of vitiligo.

Sign in / Sign up

Export Citation Format

Share Document